These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Classification and description of frontotemporal dementias. Neary D; Snowden JS; Mann DM Ann N Y Acad Sci; 2000; 920():46-51. PubMed ID: 11193176 [TBL] [Abstract][Full Text] [Related]
12. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Sampathu DM; Neumann M; Kwong LK; Chou TT; Micsenyi M; Truax A; Bruce J; Grossman M; Trojanowski JQ; Lee VM Am J Pathol; 2006 Oct; 169(4):1343-52. PubMed ID: 17003490 [TBL] [Abstract][Full Text] [Related]
14. Frontotemporal dementia: clinicopathological correlations. Forman MS; Farmer J; Johnson JK; Clark CM; Arnold SE; Coslett HB; Chatterjee A; Hurtig HI; Karlawish JH; Rosen HJ; Van Deerlin V; Lee VM; Miller BL; Trojanowski JQ; Grossman M Ann Neurol; 2006 Jun; 59(6):952-62. PubMed ID: 16718704 [TBL] [Abstract][Full Text] [Related]
15. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707 [TBL] [Abstract][Full Text] [Related]
16. Relationship between ALS and the degree of cognitive impairment, markers of neurodegeneration and predictors for poor outcome. A prospective study. Rusina R; Ridzon P; Kulist'ák P; Keller O; Bartos A; Buncová M; Fialová L; Koukolík F; Matej R Eur J Neurol; 2010 Jan; 17(1):23-30. PubMed ID: 19572947 [TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type. Forno LS; Langston JW; Herrick MK; Wilson JD; Murayama S Acta Neuropathol; 2002 Jun; 103(6):599-606. PubMed ID: 12012092 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. Josephs KA; Tsuboi Y; Cookson N; Watt H; Dickson DW Arch Neurol; 2004 Oct; 61(10):1579-84. PubMed ID: 15477512 [TBL] [Abstract][Full Text] [Related]